IDSA warns of potential loss of US measles elimination status
-
By
-
Kerri Ann DeCindis
-
November 12, 2026
-
2 min
Clinical Scorecard: IDSA warns of potential loss of US measles elimination status
At a Glance
Category | Detail |
|---|---|
Condition | Measles and the expected loss of U.S. measles elimination status |
Key Mechanisms | Elimination means continuous transmission has been interrupted for at least 12 months; loss of status would signal reestablished sustained transmission. |
Target Population | U.S. communities affected by measles, with particular concern about long-term consequences for infants who contract the infection |
Care Setting | U.S. public health response, including state and local health departments and infectious diseases specialists |
Key Highlights
IDSA warned that the expected loss of U.S. measles elimination status would reverse decades of public health progress.
Findings presented at IDWeek 2026 showed a 284.5% increase in measles PCR testing volume and a 71.6% increase in positivity rates from April 2025 through March 2026 compared with the preceding year.
According to IDSA’s statement, more than 5,000 people had been diagnosed with measles and eight deaths had been reported in the United States in 2026.
IDSA President Wendy S. Armstrong, MD, FIDSA, highlighted potential long-term consequences for infants who contract measles, including a potentially fatal neurologic complication that can develop years after infection.
Armstrong urged stronger vaccination efforts, collaboration with the Pan American Health Organization, increased health department funding and expanded support for infectious diseases specialists.
Guideline-Based Recommendations
The source reports an IDSA public health statement and selected testing findings rather than a clinical guideline.
Diagnosis
The article cites increases in measles PCR testing volume and positivity rates during the reported period.
It does not provide a diagnostic algorithm, testing indications or specimen-collection recommendations.
Management
Armstrong urged government leaders to promote measles vaccination and strengthen disease prevention efforts.
She called for increased funding for state and local health departments and expanded support for infectious diseases specialists.
The source does not describe medication regimens or individual patient treatment.
Monitoring & Follow-up
Armstrong called for collaboration with the Pan American Health Organization to restore elimination status.
The article explains that elimination requires interruption of continuous transmission for at least 12 months.
It does not specify individual patient follow-up schedules.
Risks
IDSA described the reemergence of measles as a threat to communities nationwide and cited preventable deaths.
Armstrong raised concerns about potentially fatal neurologic disease developing years after infection in infants who contract measles.
Loss of elimination status would signal sustained transmission; the source describes that loss as expected, not confirmed.
Patient & Prescribing Data
IDSA reported more than 5,000 measles diagnoses and eight deaths in the United States in 2026.
The testing findings cover April 2025 through March 2026 and represent comparisons with the preceding year. They concern testing volume and positivity rates, rather than a reported percentage increase in national case counts.
The article provides no prescribing data, vaccine dosing schedule or medication treatment regimen.
Clinical Best Practices
Promote measles vaccination and disease prevention, as urged by Armstrong.
Support state and local health departments and infectious diseases specialists.
Collaborate with the Pan American Health Organization on restoring elimination status.
Preserve the distinction between increased testing, increased positivity and reported diagnoses when communicating the findings.
Related Resources & Content
IDSA warns of potential loss of US measles elimination status — Kerri Ann DeCindis — IDSA Reporter — November 12, 2026 — Source article.
U.S. loss of measles elimination status would be a major public health setback — Wendy S. Armstrong — Infectious Diseases Society of America — Updated November 12, 2026 — IDSA statement. idsociety.org
Measles testing, positivity rates continue to rise nationwide — Julia Cipriano — IDSA Reporter — October 21, 2026 — Related report. idsareporter.com
About Measles — Centers for Disease Control and Prevention — CDC, Measles (Rubeola) — April 29, 2026 — CDC overview.
Based on findings from:
IDSA warns of potential loss of US measles elimination status
Kerri Ann DeCindis. Idsa Reporter, 2026.
https://idsareporter.com/issues/2026/november-2026/idsa-warns-of-potential-loss-of-us-measles-elimination-status/
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.